Market revenue in 2023 | USD 42.2 million |
Market revenue in 2030 | USD 75.7 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | System and Technology Support Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.67% in 2023. Horizon Databook has segmented the Japan clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
In Asia Pacific, Japan dominated the market in terms of market share and accounted for 40.46% of the market. With an enhanced clinical trial infrastructure, Japan offers a beneficial development environment for biotechnology, medical devices, and pharmaceutical companies.
These changes comprised creating a more welcoming & well-organized approach to trials, novel systems for consultation, and providing new subsidies to minimize clinical & regulatory cost for accelerated review while maintaining universal standards such as the ICH-GCP.
Clinical trials in Japan register patients very rapidly. In fact, Japan is the fastest country with regard to patient enrollment in Asia Pacific region. At the same time, Japan is the most expensive country in the region for conducting clinical trials.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Japan clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account